Company · CIK 0001729427 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
CNS Pharmaceuticals, Inc. · CNSP
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 14, 2026 MForm 4 → | Aug 18, 9:00 am EDT | Rami LevinCEO and President | 4,750 | — | — | 4,750 | — | |
| May 18, 2026 PForm 4 → | Aug 18, 9:01 am EDT | Michal FisherDirector | 2,000 | $5.00 | $10,000 | 2,000 | — | late |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 14, 2026 MForm 4 → | Aug 18, 9:00 am EDT | Rami LevinCEO and President | 4,750 | — | — | 14,250 | — |